| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.5 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |